Skip to main content
. 2020 Apr 25;19:48. doi: 10.1186/s12933-020-01014-7

Fig. 3.

Fig. 3

Changes in mean weight (a), BMI (b), total lipoprotein cholesterol (c), low density lipoprotein cholesterol (d), and 8-OHdG (e) from baseline to 52 weeks in the exenatide and insulin groups. *P < 0.05; **P < 0.01 (compared to insulin group)